US stocks SONN pre-market rise over 270%, announced the establishment of "HYPE version of micro strategy" holding 12.6 million HYPE and 300 million cash.
BlockBeats news, on July 14, the stock price of the US-listed company Sonnet BioTherapeutics Holdings, Inc. (SONN) rose 273.11% in pre-market trading, with a pre-market trading price of $19.29, an increase of $14.05 compared to the previous trading price. BlockBeats previously reported that the US-listed company Sonnet will merge to form Hyperliquid Strategies and launch a treasury strategy, holding 12.6 million tokens.
- 2